US Patent

US10420743 — Methods and compositions for the treatment of acne

Method of Use · Assigned to Sol Gel Technologies Ltd · Expires 2038-07-12 · 12y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects methods and compositions for treating acne in a subject.

USPTO Abstract

The present application is directed to regimens, methods of treatment, and compositions for the treatment of acne in a subject suffering therefrom.

Drugs covered by this patent

Benzamycin (BENZOYL PEROXIDE) · Mayne Pharma

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3194`	—	Benzamycin

Patent Metadata

Patent number: US10420743
Jurisdiction: US
Classification: Method of Use
Expires: 2038-07-12
Drug substance claim: No
Drug product claim: No
Assignee: Sol Gel Technologies Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.